Red Flags Detected
- Delisting (new) — Company received two separate Nasdaq deficiency notices for failing stockholders' equity requirements and board independence standards, creating immediate delisting risk.
- Going Concern (new) — Company disclosed substantial doubt about its ability to continue as a going concern due to capital needs and liquidity constraints.
Tempest Therapeutics faces dual Nasdaq deficiency notices for equity shortfall and board crisis
Filed May 22, 2026 · Period ending May 19, 2026 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TPST commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
View original filing on SEC.gov
Generated by AI · May 24, 2026 11:05 AM